Slide 1 May 2-6 2011 FUND FORUM Breast Cancer Supportive Care Slide 2 Symptoms and Prognosis Challenge of symptom management:Challenge of symptom management: – block toxicity…

Slide 1These slides are intended to educate the scientific and medical community and keep them fully informed about continuing progress, as is their right, stipulated by…

Kytril: a once-daily 5HT3 receptor antagonist for control of chemotherapy-induced nausea and vomiting (CINV) Frederick Schnell Central Georgia Hematology Oncology Associates…

CASE I. 40 years old male, car accident. Several fractures, hematothorax. Treatment in sufficient progress (OR). No active bleeding. No coagulopathy. No relevant medical…

Evidence, Challenges and Solutions:  Preventing and Managing Chemotherapy-Induced Nausea and Vomiting Scott Edwards, Pharm D Clinical Oncology Pharmacist Eastern Health,…

Larry R. Churchill, PhD Ann Geddes Stahlman Professor of Medical Ethics Center for Biomedical Ethics and Society Vanderbilt University Medical Center âThe belief that the…

Slide 1Larry R. Churchill, PhD Ann Geddes Stahlman Professor of Medical Ethics Center for Biomedical Ethics and Society Vanderbilt University Medical Center Slide 2 “ The…

Larry R. Churchill, PhD Ann Geddes Stahlman Professor of Medical Ethics Center for Biomedical Ethics and Society Vanderbilt University Medical Center âThe belief that the…

May 2-6 2011 FUND FORUM Breast Cancer Supportive Care Symptoms and Prognosis Challenge of symptom management: block toxicity without compromising efficacy Supportive Care…

Kytril: a once-daily 5HT3 receptor antagonist for control of chemotherapy-induced nausea and vomiting (CINV) Frederick Schnell Central Georgia Hematology Oncology Associates…